Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,619,501
-$24,885,605 QoQ
Shares Held
74,977
-93.3% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Derivatives in RCUS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$108,000
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. RCUS ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in RCUS
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,000 | 5,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,619,501 | 74,977 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $119,150 | 5,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $26,505,106 | 1,112,258 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,408,287 | 177,080 | Shares | Sole | 2026-03-31 | |
| 2025-09-30 | $17,216,240 | 1,265,900 | Call | Sole | 2026-03-31 | |
| 2025-06-30 | $2,007,893 | 246,670 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $10,304,426 | 1,265,900 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $1,434,437 | 182,731 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,683,135 | 113,038 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,814,815 | 118,693 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,213,495 | 79,678 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $3,547,003 | 187,871 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $509,760 | 27,000 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $509,760 | 27,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $3,875,256 | 202,893 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $8,450,428 | 470,776 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $3,373,348 | 166,093 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $2,963,105 | 162,451 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,606,465 | 126,038 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,413,452 | 168,710 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $904,738 | 35,704 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $964,977 | 30,576 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,343,698 | 57,912 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,946,093 | 55,810 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $166,324 | 6,057 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,037,793 | 72,571 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,196,080 | 46,074 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $993,862 | 57,985 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,290,166 | 52,149 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $207,006 | 14,914 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||